Comparing the current results to its competitors, Streamex reported Revenue increase in the 2 quarter 2026 by 0 % year on year. The revenue growth was below Streamex 's competitors' average revenue growth of 12.25 %, achieved in the same quarter.
Streamex Corp , slower than the average decrease reported by the company's competitors of -27.93 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -27.93 %
Streamex 's Comment on Competition and Industry Peers
The digital asset and real-world asset tokenization market is competitive and rapidly evolving, with participants including digital asset platforms, fintech companies, commodity market participants, digital asset exchanges, commodity trading platforms, and traditional financial services providers developing proprietary blockchain-based or digital infrastructure. Key factors in competition include regulatory compliance capabilities, technology reliability, security, integration with custodians and financial institutions, and market adoption. Several competitors possess significantly greater financial, technical, and operational resources than the Company.
Icecure Medical Ltd's business model involves the development and commercialization of innovative medical solutions, particularly focused on cryoablation technology.
Edwards Lifesciences Corporations business model focuses on the development and commercialization of advanced medical technologies that enhance the diagnosis and treatment of heart disease, emphasizing innovative heart valves and critical care monitoring solutions. The company serves a diverse customer base, including hospitals and direct-to-patient markets, with a strong commitment to improving patient outcomes and quality of life.
Encision Inc is a medical device company that designs, develops, manufactures, and markets surgical products utilizing its patented active electrode monitoring technology for precision in minimally invasive surgeries, thereby providing increased patient safety and reduced overall healthcare costs. Their business model centers around creating and selling innovative surgical devices that incorporate their unique technology to improve surgical outcomes and enhance safety in the medical field.
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Sources:
Streamex Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Streamex Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
